Borm Paul J A, Robbins David, Haubold Stephan, Kuhlbusch Thomas, Fissan Heinz, Donaldson Ken, Schins Roel, Stone Vicki, Kreyling Wolfgang, Lademann Jurgen, Krutmann Jean, Warheit David, Oberdorster Eva
Centre of Expertise in Life Sciences, Zuyd University, Heerlen, The Netherlands.
Part Fibre Toxicol. 2006 Aug 14;3:11. doi: 10.1186/1743-8977-3-11.
During the last few years, research on toxicologically relevant properties of engineered nanoparticles has increased tremendously. A number of international research projects and additional activities are ongoing in the EU and the US, nourishing the expectation that more relevant technical and toxicological data will be published. Their widespread use allows for potential exposure to engineered nanoparticles during the whole lifecycle of a variety of products. When looking at possible exposure routes for manufactured Nanoparticles, inhalation, dermal and oral exposure are the most obvious, depending on the type of product in which Nanoparticles are used. This review shows that (1) Nanoparticles can deposit in the respiratory tract after inhalation. For a number of nanoparticles, oxidative stress-related inflammatory reactions have been observed. Tumour-related effects have only been observed in rats, and might be related to overload conditions. There are also a few reports that indicate uptake of nanoparticles in the brain via the olfactory epithelium. Nanoparticle translocation into the systemic circulation may occur after inhalation but conflicting evidence is present on the extent of translocation. These findings urge the need for additional studies to further elucidate these findings and to characterize the physiological impact. (2) There is currently little evidence from skin penetration studies that dermal applications of metal oxide nanoparticles used in sunscreens lead to systemic exposure. However, the question has been raised whether the usual testing with healthy, intact skin will be sufficient. (3) Uptake of nanoparticles in the gastrointestinal tract after oral uptake is a known phenomenon, of which use is intentionally made in the design of food and pharmacological components. Finally, this review indicates that only few specific nanoparticles have been investigated in a limited number of test systems and extrapolation of this data to other materials is not possible. Air pollution studies have generated indirect evidence for the role of combustion derived nanoparticles (CDNP) in driving adverse health effects in susceptible groups. Experimental studies with some bulk nanoparticles (carbon black, titanium dioxide, iron oxides) that have been used for decades suggest various adverse effects. However, engineered nanomaterials with new chemical and physical properties are being produced constantly and the toxicity of these is unknown. Therefore, despite the existing database on nanoparticles, no blanket statements about human toxicity can be given at this time. In addition, limited ecotoxicological data for nanomaterials precludes a systematic assessment of the impact of Nanoparticles on ecosystems.
在过去几年中,关于工程纳米颗粒毒理学相关特性的研究急剧增加。欧盟和美国正在进行一些国际研究项目及其他活动,人们期望能有更多相关的技术和毒理学数据得以发表。工程纳米颗粒在各类产品的整个生命周期中都有广泛应用,这使得人们有可能接触到它们。在考虑人造纳米颗粒可能的接触途径时,吸入、经皮和经口接触最为明显,这取决于纳米颗粒所应用的产品类型。本综述表明:(1)纳米颗粒吸入后可沉积在呼吸道。对于一些纳米颗粒,已观察到与氧化应激相关的炎症反应。仅在大鼠中观察到与肿瘤相关的效应,且可能与过载情况有关。也有一些报告表明纳米颗粒可通过嗅觉上皮进入大脑。吸入后纳米颗粒可能会进入体循环,但关于其进入程度存在相互矛盾的证据。这些发现促使需要进行更多研究以进一步阐明这些结果并确定其生理影响。(2)目前,皮肤渗透研究几乎没有证据表明防晒霜中使用的金属氧化物纳米颗粒经皮应用会导致全身暴露。然而,有人提出,仅对健康、完整皮肤进行常规测试是否足够。(3)口服后纳米颗粒在胃肠道中的摄取是一个已知现象,在食品和药物成分设计中会有意利用这一现象。最后,本综述指出,仅在有限数量的测试系统中对少数特定纳米颗粒进行了研究,无法将这些数据外推至其他材料。空气污染研究为燃烧衍生纳米颗粒(CDNP)在易感人群中引发不良健康影响的作用提供了间接证据。对一些已使用数十年的块状纳米颗粒(炭黑、二氧化钛、氧化铁)进行的实验研究表明存在各种不良影响。然而,具有新化学和物理性质的工程纳米材料不断涌现,其毒性未知。因此,尽管现有关于纳米颗粒的数据库,但目前无法对人类毒性给出一概而论的说法。此外,纳米材料有限的生态毒理学数据妨碍了对纳米颗粒对生态系统影响的系统评估。